Atlas Trials

Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity

Clinical trial NCT04361474 · COMPLETED

Trial details

NCT number
NCT04361474
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
BudesonideOlfaction DisordersSARS-CoV-2Anosmia
Start date
2020-05-18
Primary completion
2020-11-24
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.